3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
114
Precursor Cell Lymphoblastic Leukemia-Lymphoma
19
Recurrence
17
Burkitt Lymphoma
14
Lymphoma, Large B-Cell, Diffuse
8
Neoplasms
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
6
Neoplasms, Plasma Cell
6
Lymphoma
6
Leukemia, Biphenotypic, Acute
5
Immunoglobulin Light-chain Amyloidosis
5
Carcinoma, Non-Small-Cell Lung
5
Prostatic Neoplasms
4
Lymphoma, Non-Hodgkin
4
Lymphoma, B-Cell
4
Waldenstrom Macroglobulinemia
3
Neoplasm Metastasis
3
Nausea
3
Lung Neoplasms
3
Leukemia
3
Smoldering Multiple Myeloma
2
Rectal Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Paraproteinemias
2
Ovarian Neoplasms
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Down Syndrome
2
Interventions
ruxolitinib
13
Cyclophosphamide
5
Tacrolimus
4
fludarabine phosphate
3
Whole-Body Irradiation
3
Stem Cell Transplantation
3
Specimen Handling
3
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
Cyclosporine
3
fludarabine
2
fedratinib
2
Sirolimus
2
Injections
2
Busulfan
2
Biopsy
2
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
2
veliparib
1
umbralisib
1
thymoglobulin
1
selinexor
1
reparixin
1
piperine
1
pegylated granulocyte colony-stimulating factor
1
navitoclax
1
luspatercept
1
letermovir
1
itacitinib
1
iadademstat
1
demethoxycurcumin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Primary Myelofibrosis
×
Dexamethasone
×
90 days
×
Clear all
No trials found.